Alphatec 

€4.92
21
+€0+0% Aujourd'hui

Statistiques

Jour Haut
4.92
Journée basse
4.92
52W Haut
-
52W Bas
-
Volume
0
Volume moyen
-
Cap boursière
811.62M
Ratio C/B
-
Rendement de dividendes
-
Dividende
-

À venir

Bénéfices

31OctPrévu
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Suivant
-0.43
-0.31
-0.19
-0.07
BPA prévu
-0.10625
BPA réel
S. O.

Sont également suivis

Cette liste est basée sur les listes de surveillance des personnes sur Stock Events qui suivent L1Z1.F. Il ne s'agit pas d'une recommandation d'investissement.

Concurrents

Cette liste est une analyse basée sur les événements récents du marché. Ce n'est pas une recommandation d'investissement.

À propos de nous

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Show more...
PDG
Mr. Patrick S. Miles
Employés
839
Pays
US
ISIN
US02081G2012
WKN
000A2AP5V

Cotation